Browse this journal

Meningococcal conjugate vaccines

Created 19 Apr 2022| Updated 20 May 2022 | 10 articles

Articles featured in this collection originally appeared in issue 16(6)

Download citations Download PDFs Download collection
Article
Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li & John L. Perez

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 29 Jun 2020
AbstractforTen-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1978 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Editorial
Progress in meningococcal conjugate vaccine development and use

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 29 Jun 2020
CitationforProgress in meningococcal conjugate vaccine development and use | Full Text | PDF (152.2 KB) | EPUB
  • 674 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W. Cutler, Marie Van Der Wielen, John L. Perez & Chris Webber

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 13 May 2020
AbstractforEfficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine | Full Text | References | PDF (1.1 MB) | EPUB
  • 1915 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study
Judith Kirstein, Miriam Pina, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 01 Apr 2020
AbstractforImmunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 2439 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study
Timo Vesikari, Ray Borrow, Aino Forsten, Helen Findlow, Mandeep S. Dhingra & Emilia Jordanov

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 01 Apr 2020
AbstractforImmunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 3400 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access
Article
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
Germán Áñez, James Hedrick, Michael W. Simon, Shane Christensen, Robert Jeanfreau, Eddy Yau, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 25 Mar 2020
AbstractforImmunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 4386 Views
  • 21 CrossRef citations
  • 0Altmetric
Open Access
Article
The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey
Hasan Tezer, Belgin Gülhan, Ayşe Simge Gişi, Selin Nar Ötgün, Saliha Kanık-Yüksek, Aslınur Özkaya-Parlakay, Selçuk Kılıç, Nuriye Ünal Şahin, Asiye Çiğdem Şimşek & Ateş Kara

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 12 Dec 2019
AbstractforThe impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey | Full Text | References | PDF (376.9 KB) | EPUB
  • 1121 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
Paolo Bonanni, Sara Boccalini, Angela Bechini, Ornella Varone, Giulio Matteo, Federica Sandri & Giovanni Gabutti

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 10 Dec 2019
AbstractforCo-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines | Full Text | References | PDF (1.3 MB) | EPUB
  • 2009 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years
Byung Wook Yoo, Hye Lim Jung, Yoon Seob Byeon, Dong Ki Han, Nak Yeong Jeong, Carlo Curina, Luca Moraschini, Sung Jin Kim, Chiranjiwi Bhusal, Michele Pellegrini & Yan Miao

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 25 Oct 2019
AbstractforResults from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1508 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies
Jerome Ateudjieu, Beat Stoll, Anne Cecile Bisseck, Ayok M. Tembei & Blaise Genton

Originally published in Human Vaccines & Immunotherapeutics, Volume: 16, Number: 6 (02 Jun 2020)

Published online: 05 Sep 2019
AbstractforSafety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies | Full Text | References | PDF (1.2 MB) | EPUB
  • 1516 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access